Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Edan

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Neurology|December 29, 2005
Idiopathic acute transverse myelitis: application of the recent diagnostic criteriaJ de Seze, C Lanctin, C Lebrun, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFITG Edan, L Kappos, X Montalbán, et al.
Genes and Immunity|July 11, 2008
HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosisI Cournu-Rebeix, E Génin, E Leray, et al.
Journal of the Neurological Sciences|June 14, 2011
Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patientsA Kerbrat, E Le Page, E Leray, et al.
Journal of Neuroimmunology|January 8, 2000
Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics GroupJ Reboul, C Mertens, F Levillayer, et al.
European Journal of Neurology|February 6, 2013
A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosisI Galea, C Lederer, A Neuhaus, et al.
Neurology|August 19, 2011
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndromeH-P Hartung, M S Freedman, C H Polman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisM S Freedman, C Metzig, L Kappos, et al.
Journal of Neurology|September 9, 2020
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosisF Lejeune, A Chatton, D-A Laplaud, et al.
Neurology|September 25, 1998
A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics GroupC Mertens, D Brassat, J Reboul, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Neurology|December 29, 2005
Idiopathic acute transverse myelitis: application of the recent diagnostic criteriaJ de Seze, C Lanctin, C Lebrun, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFITG Edan, L Kappos, X Montalbán, et al.
Genes and Immunity|July 11, 2008
HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosisI Cournu-Rebeix, E Génin, E Leray, et al.
Journal of the Neurological Sciences|June 14, 2011
Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patientsA Kerbrat, E Le Page, E Leray, et al.
Journal of Neuroimmunology|January 8, 2000
Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics GroupJ Reboul, C Mertens, F Levillayer, et al.
European Journal of Neurology|February 6, 2013
A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosisI Galea, C Lederer, A Neuhaus, et al.
Neurology|August 19, 2011
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndromeH-P Hartung, M S Freedman, C H Polman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysisM S Freedman, C Metzig, L Kappos, et al.
Journal of Neurology|September 9, 2020
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosisF Lejeune, A Chatton, D-A Laplaud, et al.
Neurology|September 25, 1998
A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics GroupC Mertens, D Brassat, J Reboul, et al.
Pageof 13